Independent prediction factors for primary patency loss in arteriovenous grafts within six months

Mauricio Monroy-Cuadros1, Serdar Yilmaz, Anastasio Salazar-Bañuelos

  • 1Division of Transplantation, Department of Surgery, Faculty of Medicine, University of Calgary, Calgary AB, Foothills Medical Center, Calgary, AB, Canada. mauricio.monroy@albertahealthservices.ca

Insights

Arteriovenous grafts (AVGs) often fail early in hemodialysis patients. Low blood flow, diabetes, older age, and peripheral vascular disease are key risk factors for AVG failure, necessitating closer monitoring.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Clinical Epidemiology

Background:

  • Arteriovenous grafts (AVGs) are crucial vascular access for chronic hemodialysis.
  • Early loss of functional patency in AVGs leads to increased reliance on catheters.
  • Identifying risk factors for AVG failure is essential for optimizing patient care.

Purpose of the Study:

  • To investigate associations between demographic and clinical factors and early loss of primary functional patency in AVGs.
  • To identify patient characteristics that predict failure of AVGs within six months of use.
  • To inform strategies for improving AVG longevity and reducing catheter dependence.

Main Methods:

  • Retrospective analysis of chronic hemodialysis patients with AVGs.
  • Comparison of demographic and clinical variables between patients with and without loss of primary functional patency.
  • Multivariable logistic regression to identify independent predictors of primary patency loss.

Main Results:

  • Primary failure occurred in 30% of AVGs.
  • Low initial intra-access blood flow (<650 mL/min) was strongly associated with patency loss (OR 31).
  • Diabetes (OR 3.5), older age (>65 years, OR 3.2), and peripheral vascular disease (OR 2.5) were also independent risk factors for AVG failure.

Conclusions:

  • Specific patient characteristics predict early failure of arteriovenous grafts.
  • Close monitoring of AVGs in patients with identified risk factors may improve access longevity.
  • Understanding these factors can help select appropriate vascular access for hemodialysis patients.
Abstract